Essilor has obtained a majority stake in Omega Optix, the leading chain of prescription laboratories in the Czech Republic and Slovakia, in a bid to expand in Eastern Europe. Omega generates revenues of more than €10 million. It will continue to operate independently under its current management.
Buying a membership today will give you:
To continue reading this article register now.